Sytrinol® supports cardiovascular health and healthy cholesterol levels.

Sytrinol has shown in a double-blind, placebo-controlled trial to significantly decrease total cholesterol, LDL-C and total triglycerides, while increasing HDL-C. In a serum bioavailability study, the Polymethoxylated Flavones, Tangeretin and Nobiletin, were significantly more bioavailable in soft gel delivery form than in either a two-piece hard shell capsule or hard shell capsule + lecithin. Sytrinol works on cholesterol production within cells rather than on dietary cholesterol.

Sytrinol is Kosher certified, non-irradiated, non-ETO treated, non-GMO, vegetarian, and has received Self-Determined GRAS status. It is available for use in soft gel, capsule and tablet delivery forms. For patent information, please go to the Next Pharmaceuticals website.